Nearly two billion people could have fatty liver disease by 2050, marking a silent global health crisis linked to rising ...
A small cluster of damaged immune cells can do outsized harm. That is the picture emerging from new research at UCLA, where ...
Scientists at UCLA have uncovered a medical breakthrough that could be a potential miracle for millions of Los Angeles ...
The liver often signals distress quietly through fatigue, appetite loss, subtle body changes, and skin or digestive signs.
A newly identified population of dysfunctional immune cells may play a central role in both aging and chronic disease.
Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...
Introduction The global rise in obesity and metabolic syndrome has increased metabolic dysfunction-associated steatotic liver disease (MASLD) incidence. Owing to its high prevalence and the emergence ...
I stared at the MRI scan on my computer screen with a mixture of alarm and disbelief. The large pink swathes coating my ...
Early screening for liver disease in type 2 diabetes is crucial for improving patient outcomes and preventing severe ...
Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal ...
Despite its scale, steatotic liver disease remains largely absent from global and US noncommunicable disease strategies.
The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results